Claims-based algorithm to define breast cancer recurrence in seer-medicare data

被引：0
|
作者：
Bates, Benjamin [1 ]
Setoguchi, Soko [2 ]
机构：
[1] Rutgers Ctr Pharmacoepidemiol & Treatment Sci, New Brunswick, NJ USA
[2] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
966
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [31] Impact of Preoperative MRI on the Surgical Treatment of Breast Cancer: A SEER-Medicare Analysis
    Thorsen, C. M.
    Weiss, J. E.
    Kerlikowske, K.
    Ozanne, E. M.
    Buist, D. S.
    Hubbard, R. A.
    Tosteson, A. N.
    Henderson, L. M.
    Virnig, B. A.
    Goodrich, M. E.
    Onega, T. L.
    CANCER RESEARCH, 2012, 72
  • [32] Prevalence of preexisting mental illness in SEER-Medicare breast cancer patients.
    Haskins, Cole Brandon
    McDowell, Bradley D.
    Carnahan, Ryan
    Fiedorowicz, Jess
    Wallace, Robert B.
    Smith, Brian J.
    Chrischilles, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: REGARDS Study Linked with Medicare Claims
    Kumamaru, Hiraku
    Judd, Suzanne E.
    Curtis, Jeffrey R.
    Ramachandran, Rekha
    Hardy, N. Chantelle
    Rhodes, J. David
    Safford, Monika M.
    Kissela, Brett M.
    Howard, George
    Jalbert, Jessica J.
    Brott, Thomas G.
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 451 - 451
  • [34] Utility of the SEER-Medicare data to identify chemotherapy use
    Warren, JL
    Harlan, LC
    Fahey, A
    Virnig, BA
    Freeman, JL
    Klabunde, CN
    Cooper, GS
    Knopf, KB
    MEDICAL CARE, 2002, 40 (08) : 55 - 61
  • [35] Treatment of localized prostate cancer: A survival analysis using seer-Medicare data
    Wong, YN
    Wan, F
    Mitra, N
    Localio, R
    Montagnet, C
    Hudes, G
    Armstrong, K
    JOURNAL OF UROLOGY, 2006, 175 (04): : 212 - 212
  • [36] Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data (Vol 15, 4333, 2023)
    Wieder, Robert
    Adam, Nabil
    CANCERS, 2024, 16 (13)
  • [37] Validity of a claims-based algorithm to identify lactic acidosis in US Medicare
    Ritchey, Mary E.
    Chen, Haoqian
    Khalil, Steve
    Bhagat, Amar
    Madu, Chioma
    Sharma, Pranav
    Huang, Cecilia
    Setoguchi, Soko
    Strom, Brian L.
    Gerhard, Tobias
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 576 - 576
  • [38] Comparison of SEER Treatment Data With Medicare Claims
    Noone, Anne-Michelle
    Lund, Jennifer L.
    Mariotto, Angela
    Cronin, Kathleen
    McNeel, Timothy
    Deapen, Dennis
    Warren, Joan L.
    MEDICAL CARE, 2016, 54 (09) : E55 - E64
  • [39] Treatment workload by stage and subtype in patients with breast cancer: A SEER-Medicare analysis.
    Cheng, Alex
    Warner, Jeremy Lyle
    Levy, Mia Alyce
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population
    Chen, Lu
    Chubak, Jessica
    Boudreau, Denise M.
    Barlow, William E.
    Weiss, Noel S.
    Li, Christopher I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (11) : 1603 - 1610
12345